Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Botvinikova (Dniepropetrovsk, Ukraine), L. Konopkina (Dniepropetrovsk, Ukraine), O. Myronenko (Dniepropetrovsk, Ukraine), O. Plekhanova (Dniepropetrovsk, Ukraine). The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA). 3297

Member's Comments

No comment yet.

Related content which might interest you: Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA) Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Evaluation of galactomannan (GM) antigen in patients with rheumatoid arthritis (RA) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 The lung in rheumatoid arthritis: drugs versus underlying disease Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective Year: 2009 Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008 Are smoking and COPD associated with ILD onset in rheumatoid arthritis? Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts) Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Risk factors of interstitial lung diseases in patients with rheumatoid arthritis. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Interstitial lung disease (ILD) in patients with polymyositis/dermatomyositis (PM/DM): clinical features and response to treatment in 6 cases Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001 Pulmonary manifestations in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 Pulmonary involvement in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 381s Year: 2006 Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 BAL features in patients with systemic scleroris (SSc) Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients Source: Eur Respir J 2014; 44: 1082-1085 Year: 2014 Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Rituximab improves interstitial lung disease in rheumatoid arthritis patients Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017